Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022

SELL
$0.49 - $1.2 $20,090 - $49,200
-41,000 Reduced 98.25%
729 $0
Q4 2021

Feb 02, 2022

SELL
$1.86 - $3.36 $385 - $695
-207 Reduced 0.49%
41,729 $94,000
Q3 2021

Nov 02, 2021

SELL
$1.52 - $3.82 $50,257 - $126,304
-33,064 Reduced 44.09%
41,936 $143,000
Q2 2021

Aug 02, 2021

BUY
$2.66 - $3.47 $199,500 - $260,250
75,000 New
75,000 $224,000

Others Institutions Holding INFI

About INFINITY PHARMACEUTICALS, INC.


  • Ticker INFI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 89,277,904
  • Description
  • Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...
More about INFI
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.